Cargando…
What defines an efficacious COVID-19 vaccine? A review of the challenges assessing the clinical efficacy of vaccines against SARS-CoV-2
The novel coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has caused more than 1 million deaths in the first 6 months of the pandemic and huge economic and social upheaval internationally. An efficacious vaccine is essential to prevent further morbidity and mortality. Alth...
Autores principales: | Hodgson, Susanne H, Mansatta, Kushal, Mallett, Garry, Harris, Victoria, Emary, Katherine R W, Pollard, Andrew J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7837315/ https://www.ncbi.nlm.nih.gov/pubmed/33125914 http://dx.doi.org/10.1016/S1473-3099(20)30773-8 |
Ejemplares similares
-
Vaccine nationalism and internationalism: perspectives of COVID-19 vaccine trial participants in the United Kingdom
por: Vanderslott, Samantha, et al.
Publicado: (2021) -
The collective voice of early phase COVID-19 vaccine trial participants: Insights for improving confidence in novel vaccines
por: Thomas, Tonia M., et al.
Publicado: (2023) -
SARS-CoV-2 vaccination efficacy on hospitalisation and variants
por: Rozencwajg, Sacha, et al.
Publicado: (2021) -
SARS-CoV-2 vaccination efficacy on hospitalisation and variants
por: Rozencwajg, Sacha, et al.
Publicado: (2021) -
Immunogenicity and protective efficacy of GBP510/AS03 vaccine against SARS-CoV-2 delta challenge in rhesus macaques
por: Jacob-Dolan, Catherine, et al.
Publicado: (2023)